TSE:COV Stock Latest News
Company AnnouncementsCovalon to Spotlight IV Pathway Protection Portfolio at 2026 ANCC Magnet Conference2w ago
Company AnnouncementsCovalon’s Collagen Dressing Shows Strong Real-World Performance in Hard-to-Heal Wounds1M ago
Company AnnouncementsCovalon to Spotlight Record Quarter at Smallcap Discoveries Conference1M ago
Company AnnouncementsCovalon’s Contamination Protection Drives Record Q3 Revenue and Margins2M ago
Pre-EarningsCOV Upcoming Earnings Report: What to Expect?2M agoCOV
Company AnnouncementsCovalon Sets August 27 Call to Discuss Q3 2026 Results2M ago
Company AnnouncementsCovalon Builds Momentum in Vascular Access, Infection Prevention and Wound Care7M ago
- Company AnnouncementsCovalon Highlights Infection Prevention Leadership at Infusion Nurses Society 2026 Meeting7M ago
- Company AnnouncementsCovalon Grants Deferred Share Units to Directors Under Updated Incentive Plan7M ago
- Company AnnouncementsCovalon Shareholders Approve All Resolutions at 2025 Annual Meeting7M ago
- Company AnnouncementsCovalon Sets Virtual-Only Annual Shareholder Meeting for March 25, 20267M ago
Company AnnouncementsCovalon Sets Virtual-Only Annual Shareholder Meeting for March 25, 20267M ago
Company AnnouncementsCovalon Posts Near Break-Even Q1 as Clinical Wins and U.S. Contracts Bolster 2026 Outlook8M ago
Company AnnouncementsCovalon Partners with AVA and Dr. Nancy Moureau on IV Infection Prevention Webinar8M ago
- Company AnnouncementsCovalon Sets February 25 Call to Review Q1 Fiscal 2026 Results8M ago
- Company AnnouncementsCovalon Sets Date and Call for Q1 Fiscal 2026 Results8M ago
Company AnnouncementsCovalon Technologies Achieves Record Revenue and Pays First-Ever Dividend11M ago
Company AnnouncementsCovalon Technologies Achieves Record Revenue and Strategic Milestones in 202511M ago
Pre-EarningsCOV Earnings this Week: How Will it Perform?11M agoCOV
